About Base Genomics
Base Genomics is a company based in Oxford (United Kingdom) founded in 2019 by Chunxiao Song, Oliver Waterhouse, and Yibin Liu was acquired by Exact Sciences in October 2020.. Base Genomics has raised $11 million across 1 funding round from investors including Exact Sciences and Oxford Science Enterprises. The company has 19 employees as of December 31, 2021. Base Genomics operates in a competitive market with competitors including Denali Therapeutics, MiRagen, Poseida Therapeutics, Castle Biosciences and Personalis, among others.
- Headquarter Oxford, United Kingdom
- Employees 19 as on 31 Dec, 2021
- Founders Chunxiao Song, Oliver Waterhouse, Yibin Liu
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Exact Sciences Innovation, Ltd
- Date of Incorporation 17 Jul, 2019
- Jurisdiction LONDON, ENGLAND
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$11 M (USD)
in 1 rounds
-
Latest Funding Round
$11 M (USD), Seed
Jun 03, 2020
-
Investors
Exact Sciences
& 1 more
-
Employee Count
19
as on Dec 31, 2021
-
Acquired by
Exact Sciences
(Oct 27, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Base Genomics
Base Genomics has successfully raised a total of $11M through 1 strategic funding round. The most recent funding activity was a Seed round of $11 million completed in June 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $11.0M
-
First Round
First Round
(03 Jun 2020)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2020 | Amount | Seed - Base Genomics | Valuation | Oxford Science Enterprises |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Base Genomics
Base Genomics has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Exact Sciences and Oxford Science Enterprises. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment management services for science ventures are provided in Oxford.
|
Founded Year | Domain | Location | |
|
Non-invasive molecular diagnostic tests for cancer detection are provided.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Base Genomics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Base Genomics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Base Genomics Comparisons
Competitors of Base Genomics
Base Genomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Denali Therapeutics, MiRagen, Poseida Therapeutics, Castle Biosciences and Personalis, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| domain | founded_year | HQ Location |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies
|
|
| domain | founded_year | HQ Location |
Precision diagnostic and prognostic tests are developed by Castle Biosciences.
|
|
| domain | founded_year | HQ Location |
Genomic sequencing and diagnosis software is provided for healthcare.
|
|
| domain | founded_year | HQ Location |
Therapeutics for aging diseases are developed by targeting senescent cells.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Base Genomics
When was Base Genomics founded?
Base Genomics was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Where is Base Genomics located?
Base Genomics is headquartered in Oxford, United Kingdom. It is registered at Oxford, Oxfordshire, United Kingdom.
Who is the current CEO of Base Genomics?
Oliver Waterhouse is the current CEO of Base Genomics. They have also founded this company.
Is Base Genomics a funded company?
Base Genomics is a funded company, having raised a total of $11M across 1 funding round to date. The company's 1st funding round was a Seed of $11M, raised on Jun 03, 2020.
How many employees does Base Genomics have?
As of Dec 31, 2021, the latest employee count at Base Genomics is 19.
What does Base Genomics do?
Base Genomics was founded in 2019 in Oxford, United Kingdom, and operates in the biotechnology sector focused on epigenetics. TET-assisted pyridine borane sequencing (TAPS) technology is provided for DNA methylation analysis via bisulfite sequencing, enabling early cancer detection and personalized medicine from samples. Additional services include non-invasive prenatal testing, single-cell sequencing, and biomarker discovery.
Who are the top competitors of Base Genomics?
Base Genomics's top competitors include Personalis, Poseida Therapeutics and Denali Therapeutics.
Who are Base Genomics's investors?
Base Genomics has 2 investors. Key investors include Exact Sciences, and Oxford Science Enterprises.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.